Global Anorexiants 麻豆原创 Research Report 2023

Publication ID:

PB503232809

Publication Date:

March 9, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Anorexiants听are used to treat obesity. Anorexiants suppress the appetite control and increases the basal metabolic rate of the individual.
Highlights
The global Anorexiants market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Anorexiants is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Anorexiants is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Anorexiants in Hospital Pharmacy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Anorexiants include Akrimax Pharmaceuticals, Teva, Johnson & Johnson, Roche, Arena Pharmaceuticals, Novo Nordisk, Abbott, Epic Pharma and Recordati Rare Diseases, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anorexiants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anorexiants.
The Anorexiants market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anorexiants market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anorexiants companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Akrimax Pharmaceuticals
Teva
Johnson & Johnson
Roche
Arena Pharmaceuticals
Novo Nordisk
Abbott
Epic Pharma
Recordati Rare Diseases
Segment by Type
Oral Anorexiants
Subcutaneous Anorexiants
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anorexiants companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Anorexiants 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral Anorexiants
1.2.3 Subcutaneous Anorexiants
1.3 麻豆原创 by Application
1.3.1 Global Anorexiants 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anorexiants 麻豆原创 Perspective (2018-2029)
2.2 Anorexiants Growth Trends by Region
2.2.1 Global Anorexiants 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anorexiants Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Anorexiants Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Anorexiants 麻豆原创 Dynamics
2.3.1 Anorexiants Industry Trends
2.3.2 Anorexiants 麻豆原创 Drivers
2.3.3 Anorexiants 麻豆原创 Challenges
2.3.4 Anorexiants 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anorexiants Players by Revenue
3.1.1 Global Top Anorexiants Players by Revenue (2018-2023)
3.1.2 Global Anorexiants Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Anorexiants 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anorexiants Revenue
3.4 Global Anorexiants 麻豆原创 Concentration Ratio
3.4.1 Global Anorexiants 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anorexiants Revenue in 2022
3.5 Anorexiants Key Players Head office and Area Served
3.6 Key Players Anorexiants Product Solution and Service
3.7 Date of Enter into Anorexiants 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Anorexiants Breakdown Data by Type
4.1 Global Anorexiants Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Anorexiants Forecasted 麻豆原创 Size by Type (2024-2029)
5 Anorexiants Breakdown Data by Application
5.1 Global Anorexiants Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Anorexiants Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Anorexiants 麻豆原创 Size (2018-2029)
6.2 North America Anorexiants 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Anorexiants 麻豆原创 Size by Country (2018-2023)
6.4 North America Anorexiants 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anorexiants 麻豆原创 Size (2018-2029)
7.2 Europe Anorexiants 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Anorexiants 麻豆原创 Size by Country (2018-2023)
7.4 Europe Anorexiants 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anorexiants 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Anorexiants 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Anorexiants 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Anorexiants 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anorexiants 麻豆原创 Size (2018-2029)
9.2 Latin America Anorexiants 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Anorexiants 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Anorexiants 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anorexiants 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Anorexiants 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Anorexiants 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Anorexiants 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Akrimax Pharmaceuticals
11.1.1 Akrimax Pharmaceuticals Company Detail
11.1.2 Akrimax Pharmaceuticals Business Overview
11.1.3 Akrimax Pharmaceuticals Anorexiants Introduction
11.1.4 Akrimax Pharmaceuticals Revenue in Anorexiants Business (2018-2023)
11.1.5 Akrimax Pharmaceuticals Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Anorexiants Introduction
11.2.4 Teva Revenue in Anorexiants Business (2018-2023)
11.2.5 Teva Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Anorexiants Introduction
11.3.4 Johnson & Johnson Revenue in Anorexiants Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Anorexiants Introduction
11.4.4 Roche Revenue in Anorexiants Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Arena Pharmaceuticals
11.5.1 Arena Pharmaceuticals Company Detail
11.5.2 Arena Pharmaceuticals Business Overview
11.5.3 Arena Pharmaceuticals Anorexiants Introduction
11.5.4 Arena Pharmaceuticals Revenue in Anorexiants Business (2018-2023)
11.5.5 Arena Pharmaceuticals Recent Development
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Detail
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Anorexiants Introduction
11.6.4 Novo Nordisk Revenue in Anorexiants Business (2018-2023)
11.6.5 Novo Nordisk Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Anorexiants Introduction
11.7.4 Abbott Revenue in Anorexiants Business (2018-2023)
11.7.5 Abbott Recent Development
11.8 Epic Pharma
11.8.1 Epic Pharma Company Detail
11.8.2 Epic Pharma Business Overview
11.8.3 Epic Pharma Anorexiants Introduction
11.8.4 Epic Pharma Revenue in Anorexiants Business (2018-2023)
11.8.5 Epic Pharma Recent Development
11.9 Recordati Rare Diseases
11.9.1 Recordati Rare Diseases Company Detail
11.9.2 Recordati Rare Diseases Business Overview
11.9.3 Recordati Rare Diseases Anorexiants Introduction
11.9.4 Recordati Rare Diseases Revenue in Anorexiants Business (2018-2023)
11.9.5 Recordati Rare Diseases Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Akrimax Pharmaceuticals
Teva
Johnson & Johnson
Roche
Arena Pharmaceuticals
Novo Nordisk
Abbott
Epic Pharma
Recordati Rare Diseases

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.